(Q44478465)

English

A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters (English)

1 reference

Europe PubMed Central

3 December 2017

amyotrophic lateral sclerosis

0 references

1 reference

based on heuristic

inferred from title

author name string

H Ryberg

1

1 reference

Europe PubMed Central

3 December 2017

H Askmark

2

1 reference

Europe PubMed Central

3 December 2017

L I Persson

3

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

3 December 2017

Acta Neurologica Scandinavica

1 reference

Europe PubMed Central

3 December 2017

108

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

1-8

1 reference

Europe PubMed Central

3 December 2017

The role of excitotoxicity in neurodegenerative disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Analysis of CSF amino acids in young patients with generalised refractory epilepsy during an add-on study with lamotrigine.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Antiglutamatergic therapy in Alzheimer's disease--effects of lamotrigine. Short communication.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Alteration in amino acids in motor neurons of the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Branched-chain amino acids and ALS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? The Italian ALS Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Prevention by lamotrigine, MK-801 and N omega-nitro-L-arginine methyl ester of motoneuron cell death after neonatal axotomy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

The administration of guanidine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

A method of quantification for the evaluation of antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

21 January 2018

Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Separation of amino acid enantiomers and chiral amines using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain metabolism of branched-chain amino acids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00111.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0404.2003.00111.X

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44478465&oldid=2025272894"